Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
基本信息
- 批准号:8818208
- 负责人:
- 金额:$ 54.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2014
- 资助国家:美国
- 起止时间:2014-09-26 至 2019-06-30
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsActininAcuteAffectAlzheimer&aposs DiseaseAutistic DisorderBindingCalmodulinCentral Nervous System DiseasesChemicalsCo-ImmunoprecipitationsComplexDLG4 geneDataEngineeringEpilepsyExhibitsF-ActinFluorescence MicroscopyFoundationsFrequenciesFunctional disorderGlutamate ReceptorHealthHippocampus (Brain)Homologous GeneInjection of therapeutic agentLinkMaintenanceMediatingMental DepressionMolecularMonitorMutateMutationN-MethylaspartateN-terminalNeuronsPeptidesPhenocopyPhysiologicalPoint MutationPost-Traumatic Stress DisordersProcessProteinsPsyche structureRoleSchizophreniaSiteStrokeStructureSynapsesSynaptic TransmissionTestingTranslatingVertebral columnWorkdiscs, large (Drosophila) homolog 2 protein, ratknock-downmutantnervous system disorderoverexpressionpostsynapticprenylationprevent
项目摘要
DESCRIPTION (provided by applicant): AMPAR and spine dysfunction or dysregulation underlies many CNS diseases including depression, autism, PTSD, epilepsy, and stroke-induced neuronal damage. Precise postsynaptic localization of AMPARs is critical for fast synaptic transmission. It depends on PSD-95 and its interaction with auxiliary AMPAR subunits called TARPs. Despite its central role in targeting AMPARs, it is unknown how PSD-95 itself is anchored at the postsynapse. Our preliminary data suggest that A) α-actinin binds to the first 13 residues of the N-terminus of PSD-95; B) knock-down (KD) of α-actinin reduces postsynaptic PSD-95 content and mEPSCs, the latter phenocopying KD of PSD-95; C) mutating either Lys10 or Lys11 to Glu (K10E, K11E) specifically impairs PSD- 95 binding to α-actinin and postsynaptic targeting of PSD-95 and of AMPARs; D) peptide PSD95(1-13) displaces PSD-95 from α-actinin; E) injection of PSD95(1-13) decreases mEPSC amplitude. We hypothesize that α-actinin is critical for postsynaptic anchoring of PSD-95 and thereby AMPAR-TARP complexes. Proving this hypothesis will fundamentally advance our understanding of postsynaptic AMPAR localization. A), B), and D) are final data. Aims 1 and 2 will further scrutinize C) and E), i.e., whether mutating K10E and K11E or injecting PSD95(1-13) affect synaptic PSD-95 and AMPAR taregting using fluorescence microscopy and mEPSC. NMR structural analysis will identify residues in α-actinin that are important for PSD-95 binding. KD of endogenous α-actinin and replacement with either WT or mutant α-actinin will show whether mutant α-actinin is not able to rescue the KD effect on PSD-95, in contrast to our rescue with WT α-actinin. Aim 3 is to test whether NMDA-induced Ca2+ influx displaces PSD-95 from α-actinin and thereby from postsynaptic sites along with AMPARs via calmodulin (CaM). We found that Ca2+/CaM binds to the N-terminus of PSD-95 to dislodge α-actinin. Our structural NMR analysis of a complex between Ca2+/CaM and the first 71 aa of PSD-95 identified Y12 in PSD-95 as critical for CaM binding. Mutating Y12 to Glu (Y12E) prevents Ca2+/CaM binding without affecting α-actinin binding or postsynaptic localization of PSD-95. NMDA-induced Ca2+ influx displaces a portion of WT but not Y12E PSD-95 from spines. In fact, Y12E exhibits a large increase rather than decrease in spines upon Ca2+ influx. We will test whether this mutation and other manipulations unmask a mechanism that leads to postsynaptic accumulation of PSD-95 and AMPARs rather than their decrease. Such a decrease is usually seen following 5 min NMDA treatment and is referred to as chemical LTD. This exciting new direction will elucidate how Ca2+ influx can cause LTD rather than LTP.
描述(由应用提供):AMPAR和脊柱功能障碍或功能障碍是许多中枢神经系统疾病的基础,包括抑郁症,自闭症,PTSD,癫痫和中风诱导的神经元损害。 AMPAR的精确突触后定位对于快速突触传播至关重要。它取决于PSD-95及其与称为TARPS的辅助AMPAR亚基的相互作用。尽管它在靶向AMPAR中的核心作用,但尚不清楚PSD-95本身如何锚定在后震荡之后。我们的初步数据表明a)α-肌动蛋白与PSD-95 N末端的前13个残基结合; b)α-肌动蛋白的敲除(KD)降低了突触后PSD-95含量和MEPSC,后者的pSD-95 kD kd; c)将lys10或lys11突变为GLU(K10E,K11E)特异性损害了PSD-95与α-肌动蛋白和PSD-95和AMPARS的突触后靶向的PSD-95; d)PEPPER PSD95(1-13)从α-肌动蛋白中取代PSD-95; e)注射PSD95(1-13)会减少MEPSC放大器。我们假设α-肌动蛋白对于PSD-95的突触后锚固至关重要,从而至关重要。证明这一假设将从根本上提高我们对突触后AMPAR定位的理解。 a),b)和d)是最终数据。目标1和2将进一步仔细检查c)和e),即是使用荧光显微镜和MEPSC进行突变的K10E和K11E或注射PSD95(1-13)影响突触的PSD-95和AMPAR对。 NMR结构分析将鉴定α-肌动蛋白中的残留物对于PSD-95结合很重要。内源性α-肌动蛋白的KD和用WT或突变型α-肌动蛋白替代的KD将表明突变α-肌动蛋白是否无法挽救对PSD-95的KD效应,而WTα-肌动蛋白的营救则相反。 AIM 3是测试NMDA诱导的Ca2+影响是否从α-肌动蛋白中取代PSD-95,从而通过钙调蛋白(CAM)从突触后部位以及AMPAR以及AMPAR中取代了PSD-95。我们发现Ca2+/CAM与PSD-95的N末端结合以脱落α-肌动蛋白。我们对Ca2+/CAM与PSD-95的第一个71 AA之间的复合物的结构NMR分析,在PSD-95中识别为Y12对于CAM结合至关重要。将Y12突变为GLU(Y12E)可防止CA2+/CAM结合而不会影响PSD-95的α-肌动蛋白结合或突触后定位。 NMDA诱导的Ca2+影响会从棘中取代WT的一部分,而不是Y12E PSD-95。实际上,Y12E在Ca2+流入时刺显示刺的大幅增长而不是减少。我们将测试该突变和其他操纵是否揭示导致PSD-95和AMPAR的突触后积累的机制,而不是减少。在5分钟NMDA处理后,通常会看到这种减少,并称为Chemical Ltd。这个令人兴奋的新方向将阐明CA2+影响如何导致LTD而不是LTP。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JOHANNES W HELL其他文献
JOHANNES W HELL的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JOHANNES W HELL', 18)}}的其他基金
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:
10445917 - 财政年份:2022
- 资助金额:
$ 54.46万 - 项目类别:
Postsynaptic Signaling by Norepinephrine and cAMP
去甲肾上腺素和 cAMP 的突触后信号传导
- 批准号:
10557151 - 财政年份:2022
- 资助金额:
$ 54.46万 - 项目类别:
Detection of Synaptic Proteins with Fluorescent Molecular Rotor-labeled Peptides
使用荧光分子转子标记肽检测突触蛋白
- 批准号:
10063961 - 财政年份:2019
- 资助金额:
$ 54.46万 - 项目类别:
Dysregulation of Cav1.2 by beta amyloid peptide
β 淀粉样肽导致 Cav1.2 失调
- 批准号:
10521735 - 财政年份:2016
- 资助金额:
$ 54.46万 - 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
8935917 - 财政年份:2014
- 资助金额:
$ 54.46万 - 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
9093834 - 财政年份:2014
- 资助金额:
$ 54.46万 - 项目类别:
Signaling by cAMP within Postsynaptic Nanodomains
突触后纳米结构域内的 cAMP 信号传导
- 批准号:
8439852 - 财政年份:2012
- 资助金额:
$ 54.46万 - 项目类别:
Signaling by cAMP within postsynaptic nano domains R01NS078792
突触后纳米域内 cAMP 的信号传导 R01NS078792
- 批准号:
9066462 - 财政年份:2012
- 资助金额:
$ 54.46万 - 项目类别:
相似国自然基金
肌动蛋白交联蛋白α-actinin在子宫内膜容受态建立中的作用及调控机制
- 批准号:81671517
- 批准年份:2016
- 资助金额:57.0 万元
- 项目类别:面上项目
TGF-β1/SMAD2/α-actinin-2/Kv1.5通路在房颤心房电重构中的作用及机制研究
- 批准号:81300140
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
NHERF1调节α-actinin 4的表达对细胞微丝骨架及宫颈癌细胞转移的影响
- 批准号:81272887
- 批准年份:2012
- 资助金额:65.0 万元
- 项目类别:面上项目
α-actinin 4介导NHERF1调节细胞微丝骨架及其对肿瘤细胞黏附与迁移的影响
- 批准号:81141033
- 批准年份:2011
- 资助金额:10.0 万元
- 项目类别:专项基金项目
Ca2+-CaM信号系统与丝状真菌中人辅肌动蛋白alpha-actinin同源基因对极性生长调控的分子机理
- 批准号:30770031
- 批准年份:2007
- 资助金额:30.0 万元
- 项目类别:面上项目
相似海外基金
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
8935917 - 财政年份:2014
- 资助金额:
$ 54.46万 - 项目类别:
Molecular Mechanisms of Postsynaptic AMPA Receptor Localization
突触后 AMPA 受体定位的分子机制
- 批准号:
9093834 - 财政年份:2014
- 资助金额:
$ 54.46万 - 项目类别: